Machteld Langenberg

Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin

B S P Hellemons, Machteld Langenberg, J. Lodder et al. · BMJ · 1999 · 226 citations · Full text

Atrial fibrillation in elderly patients: prevalence and comorbidity in general practice: Fig 1

Machteld Langenberg, B S P Hellemons, J W van Ree et al. · BMJ · 1996 · 96 citations · Full text

A clinical prediction model for the presence of peripheral arterial disease — the benefit of screening individuals before initiation of measurement of the ankle—brachial index: an observational study

B.L. Bendermacher, Joep A.W. Teijink, E.M. Willigendael et al. · Vascular Medicine · 2007 · 53 citations · Full text

Symptomatic peripheral arterial disease: the value of a validated questionnaire and a clinical decision rule.

B.L. Bendermacher, Joep A.W. Teijink, E.M. Willigendael et al. · PubMed · 2006 · 31 citations

The Prevalence of Intolerance for Low-Dose Acetylsalicylacid in the Secondary Prevention of Atherothrombosis

E. Tournoij, Ron J.G. Peters, Machteld Langenberg et al. · European Journal of Vascular and Endovascular Surgery · 2009 · 31 citations · Full text

Thrombosis, Vascular Disease, Venous Thrombosis +11